Louca Jounger Sofia, Svedenlöf Johanna, Elenius Reija, Källkrans Christoffer, Scheid Emil, Ernberg Malin, Christidis Nikolaos
Division of Oral Diagnostics and Rehabilitatiowen, Department of Dental Medicine, Karolinska Institutet, Huddinge, Sweden.
Scandinavian Center for Orofacial Neuroscience (SCON), Huddinge, Sweden.
J Oral Rehabil. 2021 Jun;48(6):654-665. doi: 10.1111/joor.13148. Epub 2021 Feb 2.
The aim of this study was to investigate if intramuscular injection of sterile water can be used as a human experimental pain model that resembles clinical craniofacial muscle pain and to analyse if the effects differ between sexes.
This randomised, double-blind, placebo-controlled cross-over study included 30 healthy age-matched women and men (23.6 ± 2.4 years). At three sessions, with at least one week of washout in between, 0.2 mL of either sterile water (test-substance), hypertonic saline (58.5 mg/mL; active control) or isotonic saline (0.9 mg/mL; passive control) was randomly injected into the right masseter muscle. Pain intensity (VAS) was continuously assessed during 5 min whereafter pain duration (s) and pain area (au) were calculated; pressure pain thresholds (PPT;kPa) were recorded every 5 minutes during 30 minutes.
Sterile water evoked pain of similar intensity (74.5 ± 49.9) as hypertonic saline (74.0 ± 50.5); whereas, isotonic saline evoked low-intensity pain (11.4 ± 23.4). The pain induced by sterile water and hypertonic saline had higher intensity (P < 0.001), longer duration (P < 0.001) and larger pain area (P < 0.001) than isotonic saline. There were no significant differences in any pain variable between sterile water and hypertonic saline. The PPT did not change significantly after any substance, except for in women 5 minutes after sterile water injection (P < 0.002). Pain duration was longer in the men for all substances (P < 0.006), while the pain area was larger in women after injection of hypertonic saline (P < 0.003).
These results indicate that pain evoked by sterile water resembles clinical muscle pain and may offer a novel and simpler alternative to hypertonic saline injections.
本研究旨在探究肌肉注射无菌水是否可作为一种类似于临床颅面部肌肉疼痛的人体实验性疼痛模型,并分析性别之间的效应差异。
这项随机、双盲、安慰剂对照的交叉研究纳入了30名年龄匹配的健康男女(23.6±2.4岁)。在三个阶段,中间至少间隔一周的洗脱期,将0.2mL无菌水(测试物质)、高渗盐水(58.5mg/mL;活性对照)或等渗盐水(0.9mg/mL;阴性对照)随机注射到右侧咬肌中。在5分钟内持续评估疼痛强度(视觉模拟评分法),之后计算疼痛持续时间(秒)和疼痛面积(任意单位);在30分钟内每隔5分钟记录压痛阈值(kPa)。
无菌水诱发的疼痛强度(74.5±49.9)与高渗盐水(74.0±50.5)相似;而等渗盐水诱发的是低强度疼痛(11.4±23.4)。与等渗盐水相比,无菌水和高渗盐水诱发的疼痛强度更高(P<0.001)、持续时间更长(P<0.001)、疼痛面积更大(P<0.001)。无菌水和高渗盐水在任何疼痛变量上均无显著差异。除了女性在注射无菌水5分钟后(P<0.002),任何物质注射后压痛阈值均无显著变化。所有物质注射后男性的疼痛持续时间更长(P<0.006),而女性在注射高渗盐水后疼痛面积更大(P<0.003)。
这些结果表明,无菌水诱发的疼痛类似于临床肌肉疼痛,可能为高渗盐水注射提供一种新的、更简单的替代方法。